American College of Clinical Pharmacy
      Search      Cart
         

Adult Medicine PRN Focus Session -- Post-Op Debate: Anticoagulation vs. Aspirin for VTE Prophylaxis Following Orthopedic Surgery

Monday, October 28, 2019 from 1:45 PM to 3:15 PM EST at 3rd Floor: Trianon Ballroom

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-181-L01-P
Activity Type: An Application-Based Activity


Speakers
Setting the Stage: Causes and Prevention of Postoperative VTE Development
1:45 PM

Speakers
  • Rachel C. Wolfe, Pharm.D., BCCCPSpeaker: Rachel C. Wolfe, Pharm.D., BCCCP
    Barnes-Jewish Hospital, Saint Louis, Missouri
      View Biography


Learning Objectives
1. Review the pathophysiology involved in VTE development.
2. Identify risk factors for VTE development in the postoperative period.
3. Describe the evolving nature of postoperative VTE prophylaxis guideline recommendations.
Postoperative Prophylaxis Stance: Anticoagulation versus Aspirin
2:05 PM

Speakers
  • Jennifer Twilla, Pharm.D.Speaker: Jennifer Twilla, Pharm.D.
    Methodist University Hospital, University of Tennessee, Memphis, Tennessee
      View Biography

  • Paul P. Dobesh, Pharm.D., FCCP, BCPSSpeaker: Paul P. Dobesh, Pharm.D., FCCP, BCPS
    Professor of Pharmacy Practice, College of Pharmacy University of Nebraska Medical Center, Omaha, Nebraska
      View Biography


Learning Objectives
1. Evaluate efficacy and safety of aspirin vs. anticoagulation for VTE prophylaxis following orthopedic surgery.
2. Compare and contrast strengths and weaknesses of using aspirin vs. anticoagulation for VTE prophylaxis following orthopedic surgery.
3. Identify potential risks and benefits of utilizing aspirin vs. anticoagulation for VTE prophylaxis in the postoperative period.
4. Recommend an appropriate VTE prophylaxis regimen for a postoperative patient.